Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15523694)

  • 1. Genotype phenotype correlations in Israeli colorectal cancer patients.
    Starinsky S; Figer A; Ben-Asher E; Geva R; Flex D; Fidder HH; Zidan J; Lancet D; Friedman E
    Int J Cancer; 2005 Mar; 114(1):58-73. PubMed ID: 15523694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analyses in consecutive israeli jewish colorectal cancer patients.
    Fidder HH; Figer A; Geva R; Flex D; Schayek H; Avidan B; Meir SB; Friedman E
    Am J Gastroenterol; 2005 Jun; 100(6):1376-80. PubMed ID: 15929773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The APC p.I1307K polymorphism is a significant risk factor for CRC in average risk Ashkenazi Jews.
    Boursi B; Sella T; Liberman E; Shapira S; David M; Kazanov D; Arber N; Kraus S
    Eur J Cancer; 2013 Nov; 49(17):3680-5. PubMed ID: 23896379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of the APC gene regions involved in attenuated APC phenotype in Israeli patients with early onset and familial colorectal cancer.
    Figer A; Irmin L; Geva R; Flex D; Sulkes A; Friedman E
    Br J Cancer; 2001 Aug; 85(4):523-6. PubMed ID: 11506490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of BRCA1 and BRCA2 mutations in Ashkenazi colorectal cancer patients: preliminary study.
    Drucker L; Stackievitz R; Shpitz B; Yarkoni S
    Anticancer Res; 2000; 20(1B):559-61. PubMed ID: 10769725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analyses of colon cancer in I1307K APC mutation carriers compared with noncarriers.
    Fidder HH; Barshack I; Chen-Shtoyerman R; Onaca N; Goldberg I; Rath P; Theodor L; Bar-Meir S; Friedman E
    Dig Dis Sci; 2003 Jun; 48(6):1102-5. PubMed ID: 12822869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenomatous polyposis coli I1307K mutation in Jewish patients with different ethnicity: prevalence and phenotype.
    Drucker L; Shpilberg O; Neumann A; Shapira J; Stackievicz R; Beyth Y; Yarkoni S
    Cancer; 2000 Feb; 88(4):755-60. PubMed ID: 10679643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The I1307K APC polymorphism in Ashkenazi Jews with colorectal cancer: clinical and pathologic features.
    Locker GY; Kaul K; Weinberg DS; Gatalica Z; Gong G; Peterman A; Lynch J; Klatzco L; Olopade OI; Bomzer CA; Newlin A; Keenan E; Tajuddin M; Knezetic J; Coronel S; Lynch HT
    Cancer Genet Cytogenet; 2006 Aug; 169(1):33-8. PubMed ID: 16875934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The I1307K adenomatous polyposis coli gene variant does not contribute in the assessment of the risk for colorectal cancer in Ashkenazi Jews.
    Strul H; Barenboim E; Leshno M; Gartner M; Kariv R; Aljadeff E; Aljadeff Y; Kazanov D; Strier L; Keidar A; Knaani Y; Degani Y; Alon-Baron L; Sobol-Dvory H; Halpern Z; Arber N
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1012-5. PubMed ID: 14578136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic factors and colorectal cancer in Ashkenazi Jews.
    Locker GY; Lynch HT
    Fam Cancer; 2004; 3(3-4):215-21. PubMed ID: 15516844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age of diagnosis of colorectal cancer in HNPCC patients is more complex than that predicted by R72P polymorphism in TP53.
    Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
    Int J Cancer; 2006 May; 118(10):2479-84. PubMed ID: 16353134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.
    Shtoyerman-Chen R; Friedman E; Figer A; Carmel M; Patael Y; Rath P; Fidder HH; Bar-Meir S; Theodor L
    Genet Test; 2001; 5(2):141-6. PubMed ID: 11551102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MTHFR C677T has differential influence on risk of MSI and MSS colorectal cancer.
    Hubner RA; Lubbe S; Chandler I; Houlston RS
    Hum Mol Genet; 2007 May; 16(9):1072-7. PubMed ID: 17350979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel.
    Figer A; Irmin L; Geva R; Flex D; Sulkes J; Sulkes A; Friedman E
    Br J Cancer; 2001 Feb; 84(4):478-81. PubMed ID: 11207041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single nucleotide polymorphisms within interferon signaling pathway genes are associated with colorectal cancer susceptibility and survival.
    Lu S; Pardini B; Cheng B; Naccarati A; Huhn S; Vymetalkova V; Vodickova L; Buchler T; Hemminki K; Vodicka P; Försti A
    PLoS One; 2014; 9(10):e111061. PubMed ID: 25350395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer].
    Wang AZ; Zhu ZZ; Cong WM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):168-71. PubMed ID: 18393238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants in C-type lectin genes are associated with colorectal cancer susceptibility and clinical outcome.
    Lu S; Bevier M; Huhn S; Sainz J; Lascorz J; Pardini B; Naccarati A; Vodickova L; Novotny J; Hemminki K; Vodicka P; Försti A
    Int J Cancer; 2013 Nov; 133(10):2325-33. PubMed ID: 23650115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic cases.
    Figer A; Shtoyerman-Chen R; Tamir A; Geva R; Irmin L; Flex D; Theodor L; Sulkes A; Sadetzki S; Bar-Meir S; Friedman E
    Br J Cancer; 2001 Nov; 85(9):1368-71. PubMed ID: 11720476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.